Decatur Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
JHIU
BIT
Decatur Capital Management's BSX Position: Q4 2016 in Review
Decatur Capital Management sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 587,955 shares — an estimated $14M sold.
Decatur Capital Management first reported a position in BSX in Q3 2013 and held it in 13 quarters. The position peaked at $24.6M in Q1 2015. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.
- Decatur Capital Management reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
- Decatur Capital Management sold 587,955 Boston Scientific shares in Q4 2016, an estimated $14M.
- Decatur Capital Management first reported a position in Boston Scientific in Q3 2013 and held it in 13 quarters.
- Decatur Capital Management's Boston Scientific position peaked at $24.6M in Q1 2015.
- 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.
Based on Decatur Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.